Security key
552641102
MAIA Biotechnology, Inc. - Common Stock, $0.0001 par value per share (MAIA)
CUSIP: 552641102
Q4 2022 13F Holders as of 31 Dec 2022
- Type / Class
- Equity / Common Stock, $0.0001 par value per share
- Shares outstanding
- 60,521,183
- Total 13F shares
- 297,126
- Share change
- +65,849
- Total reported value
- $1,043,412
- Price per share
- $3.51
- Number of holders
- 6
- Value change
- +$236,126
- Number of buys
- 5
- Number of sells
- 5
Report period
Q4 2022
Institutions
6
Top holders
6
MAIA full security history
Newer quarter: Q1 2023
Previous quarter: Q3 2022
MAIA Biotechnology, Inc. SEC filings
MAIA Biotechnology, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 552641102
Recent filing periods:
Top shareholders of MAIA - MAIA Biotechnology, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Lynwood Capital Management Inc. |
13F
|
Company |
0.33%
|
199,785
|
$659,000 | — | 30 Sep 2022 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.02%
|
11,811
|
$39,000 | — | 30 Sep 2022 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.02%
|
10,210
|
$34,000 | — | 30 Sep 2022 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
4,588
|
$15,000 | — | 30 Sep 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.01%
|
3,572
|
$12,000 | — | 30 Sep 2022 | |
| OPTIMUM INVESTMENT ADVISORS |
13F
|
Company |
0%
|
1,000
|
$3,000 | — | 30 Sep 2022 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
311
|
$1,000 | — | 30 Sep 2022 | |
| Laurentiu Vlad |
3/4/5
|
Director |
—
class O/S missing
|
3,045
|
— | — | 30 Dec 2022 |
Institutional Holders of MAIA Biotechnology, Inc. - Common Stock, $0.0001 par value per share (MAIA) as of Q4 2022
As of 31 Dec 2022,
MAIA Biotechnology, Inc. - Common Stock, $0.0001 par value per share (MAIA) was held by
6 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
297,126 shares.
The largest 6 holders included
Lynwood Capital Management Inc., Centric Wealth Management, BlackRock Inc., UBS Group AG, WELLS FARGO & COMPANY/MN, and BANK OF AMERICA CORP /DE/.
This page lists
6
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2022 vs Q3 2022 Across Filers
Q3 2022 holders
7
Q4 2022 holders
6
Holder diff
-1
| Investor | Q3 2022 Shares | Q4 2022 Shares | Share Diff | Share Chg % | Q3 2022 Value $ | Q4 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.